Luxfer Holdings PLC
NYSE:LXFRIndustrial - Machinery
+$0.51 today
- Market cap
- $464.28M
- Beta
- 1.12
- P/E (TTM)
- 86.4
- EPS (TTM)
- $0.22
- Dividend yield
- 2.76%
Volume 0.58M
Average 0.18M
LXFR Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Luxfer Holdings PLCNYSE: LXFR
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables turns negative
Q1 FY2026 accounts receivables was -$10.1M, compared with $1M a year earlier. Trailing-twelve-month accounts receivables was -$6.68M.
Context
- Accounts receivables amounted to 1.1% of revenue in FY2025, unchanged from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near -$10.1M or moves back toward the trailing-twelve-month quarterly average of -$1.67M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 4.3M USD
- Year-over-year change
- +200.0%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.3M | +200.0% |
| FY2024 | 2024-12-31 | (4.3M) | -125.9% |
| FY2023 | 2023-12-31 | 16.6M | +165.6% |
| FY2022 | 2022-12-31 | (25.3M) | -158.2% |
| FY2021 | 2021-12-31 | (9.8M) | — |
Accounts Receivables vs competitors
How LXFR compares with its peers on the latest reported figures
- LXFR's LTM Mar 2026 accounts receivables of $6.68M is the 4th largest of the 11 companies compared; the peer median is $647.5K.
- Its year-over-year change of -284.5% is the lowest of 11, against a peer median of +32.7%.
- Accounts receivables amounts to 1.8% of revenue for LXFR, versus a peer median of 0.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $19.55M | -0.2% | — | 2.9% | |
| LTM Mar 2026 | $14.54M | +70.0% | — | 2.1% | |
| LTM Mar 2026 | $13.1M | -82.8% | — | 0.9% | |
| LTM Mar 2026 | $6.68M | -284.5% | — | 1.8% | |
| LTM Mar 2026 | $5.41M | +242.3% | — | — | |
| LTM Mar 2026 | $5.3M | +65.6% | -40.4% | 0.3% | |
| LTM Mar 2026 | $4.8M | +237.1% | -45.2% | 0.3% | |
| LTM Mar 2026 | $3.28M | -78.6% | — | 0.9% | |
| LTM Mar 2026 | $1.93M | +151.2% | -9.4% | 0.4% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $727.39K | -230.0% | — | 0.4% |
| LTM Mar 2026 | $633K | -221.7% | -39.1% | 0.6% | |
| Peer median (excluding LXFR) | $647.5K | +32.7% | -39.8% | 0.6% | |
Competitors are the stored peer set for LXFR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 30M | 32M | (2.6M) | 18.3M | 7.7M |
| Depreciation & Amortization | 15.6M | 18M | 12.7M | 13.4M | 9.9M |
| Deferred Income Tax | (1.6M) | 8.7M | (600K) | 1.1M | 6.2M |
| Stock-Based Compensation | 2.8M | 2.5M | 2.8M | 3.5M | 3.6M |
| Change in Working Capital | (1.2M) | (46.6M) | (8M) | 8.9M | (8.9M) |
| Accounts Receivables | (9.8M) | (25.3M) | 16.6M | (4.3M) | 4.3M |
| Inventory | (15.3M) | (25M) | 16.6M | (4.1M) | (6.7M) |
| Accounts Payables | 11.4M | 21.3M | (19M) | 4.8M | (5.7M) |
| Other Working Capital | 12.5M | (17.6M) | (22.2M) | 12.5M | (800K) |
| Other Non-Cash Items | (19.5M) | 1.3M | 22M | 5.9M | 15.5M |
| Operating Cash Flow | 26.1M | 15.9M | 26.3M | 51.1M | 34M |
| Capital Expenditures | (9.1M) | (8.3M) | (9.4M) | (10.3M) | (7.8M) |
| Acquisitions (Net) | 4.1M | (1M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (100K) | 3.6M | (100K) | 7.3M | 2.7M |
| Investing Cash Flow | (5.1M) | (5.7M) | (9.5M) | (3.4M) | (5.1M) |
| Debt Repayment | 6.4M | 24.8M | (10.2M) | (27.2M) | (7.2M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (6.4M) | (11.1M) | (2.7M) | (2.3M) | (3.1M) |
| Dividends Paid | (13.6M) | (14.2M) | (14M) | (14M) | (13.9M) |
| Other Financing Activities | (2.5M) | (1.4M) | (600K) | (500K) | (800K) |
| Financing Cash Flow | (16.1M) | (2M) | (27.5M) | (44M) | (25M) |
| Effect of Forex Changes | 0 | (1.7M) | 400K | 0 | 500K |
| Net Change in Cash | 4.9M | 6.5M | (10.3M) | 3.7M | 4.4M |
| Free Cash Flow | 17M | 7.6M | 16.9M | 40.8M | 26.2M |
Luxfer Holdings PLC
NYSE:LXFR
Intrinsic Alpha fair value
Locked
Current Price
$17.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.